The effects of Spirulina supplementation on metabolic syndrome components, its liver manifestation and related inflammatory markers: A systematic review

Complementary Therapies in Medicine

Volumn 42, Issue , 2019, Pages 137-144

  Yousefi, Reyhaneh ^a   Saidpour, Atoosa ^b   Mottaghi, Azadeh ^c  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Arthrospira; Metabolic syndrome; Spirulina

Indexed keywords

BIOLOGICAL MARKER; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BODY WEIGHT LOSS; BODY WEIGHT MANAGEMENT; DRUG MECHANISM; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INFLAMMATION; LIPID METABOLISM; LIVER DISEASE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; REVIEW; SPIRULINA; SUPPLEMENTATION; SYSTEMATIC REVIEW; ANIMAL; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECT; LIVER; METABOLISM; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; BIOMARKERS; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATION; LIVER; METABOLIC SYNDROME; NUTRITION THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPIRULINA;

EID: 85056630895     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2018.11.013     Document Type: Review

References (53)

1. Kaur, J., A comprehensive review on metabolic syndrome. Cardiol Res Pract, 2014, 2014, 943162.
2. O'Neill, S., O'Driscoll, L., Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev 16:1 (2015), 1–12.
3. Mottaghi, A., Mirmiran, P., Pourvali, K., Tahmasbpour, Z., Azizi, F., Incidence and prevalence of childhood obesity in Tehran, Iran in 2011. Iran J Public Health 46:10 (2017), 1395–1403.
4. Mottaghi, A., Mirmiran, P., Delshad, H., Azizi, F., Effect of different obesity phenotypes on incidence of chronic kidney disease in tehranian adults. J Am Coll Nutr 35:7 (2016), 587–596.
5. Khezri, S.S., Saidpour, A., Hosseinzadeh, N., Amiri, Z., Beneficial effects of Apple Cider Vinegar on weight management, Visceral Adiposity Index and lipid profile in overweight or obese subjects receiving restricted calorie diet: a randomized clinical trial. J Funct Foods 43 (2018), 95–102.
6. Yousefi, R., Mottaghi, A., Saidpour, A., Spirulina platensis effectively ameliorates anthropometric measurements and obesity-related metabolic disorders in obese or overweight healthy individuals: a randomized controlled trial. Complement Ther Med 40 (2018), 106–112.
7. Yousefi, R., Saidpour, A., Mottaghi, A., Effects of combined administration of weight reducing diet and SPIRULINA platensis on anthropometric measures and glycemic markers in obese and overweight subjects: a randomized, double-blinded, placebo-controlled clinical trial. Iran J Endocrinol Metabol 20:1 (2018), 10–21.
8. Mazokopakis, E.E., Starakis, I.K., Papadomanolaki, M.G., Mavroeidi, N.G., Ganotakis, E.S., The hypolipidaemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population: a prospective study. J Sci Food Agric 94:3 (2014), 432–437.
9. El-Sheekh, M.M., Hamad, S.M., Gomaa, M., Protective effects of Spirulina on the liver function and hyperlipidemia of rats and human. Braz Arch Biol Technol 57:1 (2014), 77–86.
10. Serban, M.C., Sahebkar, A., Dragan, S., et al. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clin Nutr 35:4 (2016), 842–851.
11. Ismail, M., Hossain, M.F., Tanu, A.R., Shekhar, H.U., Effect of spirulina intervention on oxidative stress, antioxidant status, and lipid profile in chronic obstructive pulmonary disease patients. Biomed Res Int, 2015, 2015, 486120.
12. Deng, R., Chow, T.J., Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina. Cardiovasc Ther 28:4 (2010), e33–45.
13. Park, H.J., Lee, Y.J., Ryu, H.K., Kim, M.H., Chung, H.W., Kim, W.Y., A randomized double-blind, placebo-controlled study to establish the effects of spirulina in elderly Koreans. Ann Nutr Metab 52:4 (2008), 322–328.
14. Lee, E.H., Park, J.E., Choi, Y.J., Huh, K.B., Kim, W.Y., A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients. Nutr Res Pract 2:4 (2008), 295–300.
15. Kalafati, M., Jamurtas, A.Z., Nikolaidis, M.G., et al. Ergogenic and antioxidant effects of spirulina supplementation in humans. Med Sci Sports Exerc 42:1 (2010), 142–151.
16. Ferreira-Hermosillo, A., Torres-Duran, P.V., Juarez-Oropeza, M.A., Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series. J Med Case Rep, 4, 2010, 103.
17. Karkos, P.D., Leong, S.C., Karkos, C.D., Sivaji, N., Assimakopoulos, D.A., Spirulina in clinical practice: evidence-based human applications. Evid Based Complement Alternat Med, 2011, 2011, 531053.
18. Smieszek, A., Giezek, E., Chrapiec, M., et al. The influence of Spirulina platensis filtrates on Caco-2 proliferative activity and expression of apoptosis-related microRNAs and mRNA. Mar Drugs, 15(3), 2017.
19. Nasirian, F., Dadkhah, M., Moradi-Kor, N., Obeidavi, Z., Effects of Spirulina platensis microalgae on antioxidant and anti-inflammatory factors in diabetic rats. Diabetes Metab Syndr Obes 11 (2018), 375–380.
20. Nawrocka, D., Kornicka, K., Smieszek, A., Marycz, K., Spirulina platensis improves mitochondrial function impaired by elevated oxidative stress in adipose-derived mesenchymal stromal cells (ASCs) and Intestinal Epithelial Cells (IECs), and Enhances Insulin Sensitivity in Equine Metabolic Syndrome (EMS) Horses. Mar Drugs, 15(8), 2017.
21. Marycz, K., Michalak, I., Kocherova, I., The Cladophora glomerata enriched by biosorption process in Cr(III) improves viability, and reduces oxidative stress and apoptosis in equine metabolic syndrome derived adipose mesenchymal stromal stem cells (ASCs) and their extracellular vesicles (MV's). Mar Drugs, 15(12), 2017.
22. Finamore, A., Palmery, M., Antioxidant, immunomodulating, and microbial-modulating activities of the sustainable and ecofriendly Spirulina. Oxid Med Cell Longev, 2017, 2017, 3247528.
23. Liberati, A., Altman, D.G., Tetzlaff, J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:4 (2009), W65–94.
24. Zeinalian, R., Farhangi, M.A., Shariat, A., Saghafi-Asl, M., The effects of Spirulina platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial. BMC Complement Altern Med, 17(1), 2017, 225.
25. Miczke, A., Szulinska, M., Hansdorfer-Korzon, R., et al. Effects of spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians: a double-blind, placebo-controlled, randomized trial. Eur Rev Med Pharmacol Sci 20:1 (2016), 150–156.
26. Szulinska, M., Gibas-Dorna, M., Miller-Kasprzak, E., et al. Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: a randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci 21:10 (2017), 2473–2481.
27. Mazokopakis, E.E., Papadomanolaki, M.G., Fousteris, A.A., Kotsiris, D.A., Lampadakis, I.M., Ganotakis, E.S., The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study. Ann Gastroenterol 27:4 (2014), 387–394.
28. Fujimoto, M., Tsuneyama, K., Fujimoto, T., Selmi, C., Gershwin, M.E., Shimada, Y., Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome. Dig Liver Dis 44:9 (2012), 767–774.
29. Hassan, H.A., El-Gharib, N.E., Obesity and clinical riskiness relationship: therapeutic management by dietary antioxidant supplementation–A review. Appl Biochem Biotechnol 176:3 (2015), 647–669.
30. Winter, F.S., Emakam, F., Kfutwah, A., Hermann, J., Azabji-Kenfack, M., Krawinkel, M.B., The Effect of Arthrospira platensis Capsules on CD4 T-Cells and antioxidative capacity in a randomized pilot study of adult women infected with human immunodeficiency virus not under HAART in Yaoundé. Cameroon. Nutrients. 6:7 (2014), 2973–2986.
31. Torres-Duran, P.V., Ferreira-Hermosillo, A., Juarez-Oropeza, M.A., Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: A preliminary report. Lipids Health Dis, 6, 2007, 33.
32. Soheili, M., Khosravi-Darani, K., The potential health benefits of algae and micro algae in medicine: a review on Spirulina platensis. Curr Nutr Food Sci 7:4 (2011), 279–285.
33. Parikh, P., Mani, U., Iyer, U., Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. J Med Food 4:4 (2001), 193–199.
34. Park, H.J., Lee, H.S., The influence of obesity on the effects of spirulina supplementation in the human metabolic response of Korean elderly. Nutr Res Pract 10:4 (2016), 418–423.
35. Nagaoka, S., Shimizu, K., Kaneko, H., et al. A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J Nutr 135:10 (2005), 2425–2430.
36. Bhat, V.B., Madyastha, K.M., Scavenging of peroxynitrite by phycocyanin and phycocyanobilin from Spirulina platensis: protection against oxidative damage to DNA. Biochem Biophys Res Commun 285:2 (2001), 262–266.
37. Ngo-Matip, M.E., Pieme, C.A., Azabji-Kenfack, M., et al. Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naive patients in Yaounde-Cameroon: a randomized trial study. Lipids Health Dis, 13, 2014, 191.
38. Han, L.K., Li, D.X., Xiang, L., et al. Isolation of pancreatic lipase activity-inhibitory component of spirulina platensis and it reduce postprandial triacylglycerolemia. Yakugaku Zasshi 126:1 (2006), 43–49.
39. Cheong, S.H., Kim, M.Y., Sok, D.E., et al. Spirulina prevents atherosclerosis by reducing hypercholesterolemia in rabbits fed a high-cholesterol diet. J Nutr Sci Vitaminol 56:1 (2010), 34–40.
40. Ku, C.S., Yang, Y., Park, Y., Lee, J., Health benefits of blue-green algae: Prevention of cardiovascular disease and nonalcoholic fatty liver disease. J Med Food 16:2 (2013), 103–111.
41. Marcel, A.K., Ekali, L.G., Eugene, S., et al. The effect of Spirulina platensis versus soybean on insulin resistance in HIV-infected patients: a randomized pilot study. Nutrients 3:7 (2011), 712–724.
42. Mani, U.V., Desai, S., Iyer, U., Studies on the long-term effect of spirulina supplementation on serum lipid profile and glycated proteins in NIDDM patients. J Nutraceuticals Funct Med Foods 2:3 (2000), 25–32.
43. Shah, A., Mehta, N., Reilly, M.P., Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr 32:6 (2008), 638–644.
44. Wu, Q., Liu, L., Miron, A., Klimova, B., Wan, D., Kuca, K., The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview. Arch Toxicol, 2016.
45. Riss, J., Decorde, K., Sutra, T., et al. Phycobiliprotein C-phycocyanin from Spirulina platensis is powerfully responsible for reducing oxidative stress and NADPH oxidase expression induced by an atherogenic diet in hamsters. J Agric Food Chem 55:19 (2007), 7962–7967.
46. Schafer, F.Q., Wang, H.P., Kelley, E.E., Cueno, K.L., Martin, S.M., Buettner, G.R., Comparing beta-carotene, vitamin E and nitric oxide as membrane antioxidants. Biol Chem 383:3-4 (2002), 671–681.
47. Bai, S.K., Lee, S.J., Na, H.J., et al. Beta-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation. Exp Mol Med 37:4 (2005), 323–334.
48. Sezavar, H., Saboor-Yaraghi, A.A., Salehi, E., Mottaghi, A., Whether vitamin A supplementation is effective in T-bet and IFN- gene expression reduction?. Immunol Invest 44:2 (2015), 189–198.
49. Asrih, M., Jornayvaz, F.R., Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link?. Mol Cell Endocrinol 418:Pt. 1 (2015), 55–65.
50. Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., Loria, P., Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis 47:3 (2015), 181–190.
51. Eslamparast, T., Eghtesad, S., Poustchi, H., Hekmatdoost, A., Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. World J Hepatol 7:2 (2015), 204–212.
52. Kulshreshtha, A., Zacharia, A.J., Jarouliya, U., Bhadauriya, P., Prasad, G.B., Bisen, P.S., Spirulina in health care management. Curr Pharm Biotechnol 9:5 (2008), 400–405.
53. Pan, H., She, X., Wu, H., Ma, J., Ren, D., Lu, J., Long-term regulation of the local renin-angiotensin system in the myocardium of spontaneously hypertensive rats by feeding bioactive peptides derived from Spirulina platensis. J Agric Food Chem 63:35 (2015), 7765–7774.